Financials
Financial year 2024
Worth noting
- A loss two years in a row.
Gross margin
€ 1 million
▲ 19% vs 2023
Profit
Caution€ -189,421
▼ 1684% vs 2023
Debts
High€ 1.5 million
▲ 5% vs 2023
BioLyo Technologies from Gent, company number BE0741579648, closed financial year 2024 with a result of € -189,421 after tax. For that financial year BioLyo Technologies recorded a gross margin of € 1 million and equity of € 102,586. Compared with financial year 2023, the result moved from € -10,618 to € -189,421. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2025.
What happened at BioLyo Technologies?
What happened at BioLyo Technologies in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 189,421. filed late Source: NBB ↗
- Kenneth Solovay stepped down as director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 47,256 profit in 2021 to € 189,421 loss in 2024.
Best year ever: 2021, with € 47,256 profit.
On average € 83,700 of value added per employee in 2024.
A new publication or filing at BioLyo Technologies? We notify you, reason included.
Follow BioLyo TechnologiesNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind BioLyo Technologies are Rubin Keith and Thalen Biotech Consultancy BV.
Directors
According to the 2024 annual accounts
Rubin Keith
Director
Director · represented by Marcel Thalen
Kenneth Solovay
Director
· until 2024
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 94
9052 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
Zomagen Biosciences Belgium
€ 1.2 million gross margin · 2025
AnimAb
€ 28,596 gross margin · 2025
ExeVir Bio
€ -1.2 million gross margin · 2025
Protealis
€ 1.1 million gross margin · 2025
YAKULT HONSHA EUROPEAN RESEARCH CENTER FOR MICROBIOLOGY
+1 more
Details
- Company number
- 0741.579.648
- VAT number
- BE 0741.579.648
- Registered office
- Technologiepark-Zwijnaarde 94, 9052 Gent
- Names & denominations
- BioLyo Technologies
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 January 2020
- Peppol
- Active · Active since 21 Jan 2026
- Contact
- marcel@iliadbio.com
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van farmaceutische grondstoffen